•    Call Us

      Customer Service:
      (877) 964-7800 ext. 400
      Monday-Friday 9-5 EST
      in the USA and Canada

      More Info


E-cigs on the Rise, Teenage Smoking Rates Plummet

Forbes calls Electronic Cigarettes “the most successful smoking cessation product” ever Invented

The massively popular American business magazine, Forbes, recently released a fantastic article on vaping culture and the effect of electronic cigarettes on teen smoking rates in the United States. The Smokestik team has recognized the positive health benefits of ecigs over traditional cigarettes for years, but it seems as though the general public is finally starting to take notice. When a publishing giant like Forbes comes out with a widely-shared article on the positive effects of electronic cigarettes and “vape” is the Oxford Dictionary word of the year, you can tell there is real progress being made.

The Forbes article demonstrates how teenage smoking rates have been cut in half, and “that halving of teen smoking rates coincides with the invention and introduction of vaping.” Other professional studies on electronic cigarettes have produced similar data, but some have been worried that increased ecig use could lead to eventual cigarette addiction. However, these same studies have disproved such notions: “…people use vaping equipment instead of smoking, not as a gateway to it nor does vaping increase smoking prevalence. It is thus a substitute, not a complement.”

NEW SmokeStik ULTRA Single Kit and Select eLiquid are now available! Check out all the new Kits!
Ultra-Single-Kit-Silver-L Select-eLiquid-Black Cherry-Tobacco
ULTRA Single Kit ULTRA Select eLiquid

Despite so much evidence to the contrary, some within the American health community still speak out against electronic cigarette use. This backlash against vaping, while nearly all studies  are showing positive health benefits when compared to traditional cigarettes and dramatically lower teenage smoking rates, is quite perplexing. However, most of this dissent comes from the pharmaceutical industry, and it is easy to understand why. Perhaps my favorite quotation from this article reads:

“…there’s also those over in Big Pharma who have invested very large sums (it really does cost up to $1 billion to bring a new drug to market) in various pharmaceutical smoking cessation aids. And they would be very interested in being able to market those without having to face the competition…”

Of course. Why should we be surprised? In every great movement, health-related or otherwise, there are those in financial power looking to stop the inevitable turn of the tide. However, these large corporations in the pharmaceutical industry can shell out millions of dollars on advertising all they want. Teenage smoking rates cut in half, numerous studies showing the benefits of electronic cigarettes over traditional smoking, and the widespread prevalence of ecigs in our global culture all show that vaping is here to stay.

WARNING: SmokeStik® products are intended for use by persons of legal smoking age, NOT BY nonsmokers or by children, women who are pregnant or breastfeeding, or persons with or at risk of heart disease, high blood pressure, diabetes, or taking medicine for depression or asthma. Consult a physician if you experience symptoms such as nausea, vomiting, dizziness, diarrhea, weakness and rapid heartbeat. If you smoke tobacco products, you are encouraged to stop.

SmokeStik® products are NOT smoking cessation products, have NOT been approved by the FDA, and have NOT been tested as such. Please keep SmokeStik® products out of the reach of children and pets; ingestion of certain pieces can present a choking hazard, and ingestion of large amounts of non‐vaporized concentrated ingredients in the cartridges can be poisonous.These statements and SmokeStik® products are not intended to diagnose, treat, cure, or prevent any disease.